CD8A and cancer: The synergetic effects of suppressing tumour growth and activating antitumor immunity arise from enhancement of immunogenicity of cancer antigens and activation of antitumour CD8+ T-cell responses owing to the vaccine component, as well as remedy of immunosuppressive condition owing to the checkpoint blockade.